Recurrence of renal cell carcinoma in a renal allograft after partial transplant nephrectomy: A case report

Urologia Internationalis

Volumn 83, Issue 2, 2009, Pages 239-241

  Hoda, M R ^a   Hamza, A ^a   Wagner, S ^a   Greco, F ^a   Fornara, P ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Nephron sparing surgery; Renal cell carcinoma; Renal Transplantation

Indexed keywords

CYCLOSPORIN; GADOLINIUM;

AGED; ARTICLE; CANCER RECURRENCE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DOPPLER ECHOGRAPHY; FOLLOW UP; HEMODIALYSIS; HOSPITAL DISCHARGE; HUMAN; KIDNEY ALLOGRAFT; KIDNEY CARCINOMA; KIDNEY GRAFT REJECTION; MALE; PARTIAL NEPHRECTOMY; PRIORITY JOURNAL; TUMOR DIAGNOSIS;

AGED; CARCINOMA, RENAL CELL; HUMANS; KIDNEY NEOPLASMS; KIDNEY TRANSPLANTATION; MALE; NEOPLASM RECURRENCE, LOCAL; NEPHRECTOMY; POSTOPERATIVE COMPLICATIONS;

EID: 70349269881     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000230032     Document Type: Article

References (12)

1. Kasiske B, Snyder JJ, Gilbertson DT: Cancer after kidney transplantation in the United States. Am J Transplant 2004; 4: 905-913.
2. Zani D, Simeone C, Antonelli A, Bettini E, Moroni A, Cosciani Cunico S: Cancer in kidney transplantation. Urol Int 2008; 80: 329-331.
3. Zavos G, Kakisis J, Bokos J, Pappas P, Boletis J, Kostakis A: De novo renal cell carcinoma in a kidney allograft 13 years after transplantation: A case report and review of the literature. Urol Int 2007; 78: 283-285.
4. Burama A, St-Louis G, Nicolet V, et al: Renal carcinoma in kidney allografts: A case series from a single center. Am J Transplant 2005; 5: 3015-3018.
5. Moudouni SM, Tligui M, Doublet JP, et al: Nephron-sparing surgery for de novo renal cell carcinoma in allograft kidneys. Transplantation 2005; 80: 865-867.
6. Pahernik S, Roos F, Hampel C, Gillitzer R, Melchior SW, Thüroff JW: Nephron sparing surgery for renal cell carcinoma with normal contralateral kidney: 25 years of experience. J Urol 2006; 175: 2027-2031.
7. Matevossian E, Novotny A, Vogelsang B, Mehler J, Stangl M, Thorban S, Dobritz M: Noninvasive therapy of incidental de novo renal cell carcinoma in a kidney allograft 12 years after transplantation: Report of a case and review of literature. Transplant Proc 2008; 40: 915-917.
8. Fornara P: Nephron-sparing surgery in renal cell carcinoma: did we sacrifice too many kidneys in the past? Eur Urol 2007; 51: 1475-1476.
9. Breda A, Stepanian SV, Liao J, Lam JS, Guazzoni G, Stifelman M, Perry K, Celia A, Breda G, Fornara P, Jackman S, Rosales A, Palou J, Grasso M, Pansadoro V, Disanto V, Porpiglia F, Milani C, Abbou C, Gaston R, Janetschek G, Soomro NA, de la Rosette J, Laguna MP, Schulam PG: Positive margins in laparo-scopic partial nephrectomy in 855 cases: A multi-institutional survey from the United States and Europe. J Urol 2007; 178: 47-50. (Pubitemid 46898489)
10. Goeman L, Joniau S, Oyen R, Van Poppel H: Percutaneous ultrasound-guided radiofre-quency ablation of recurrent renal cell carcinoma in renal allograft after partial ne-phrectomy. Urology 2006; 67: 199.
11. Pope JC, Koch MO, Bluth RF: Renal cell carcinoma in patients with end-stage renal disease: A comparison of clinical significance in patients receiving hemodialysis and those with renal transplants. Urology 1994; 44: 497-501.
12. Luan FL, Ding R, Sharma VK, Chon WJ, Lagman M, Suthanthiran M: Rapamycin is an effective inhibitor of human renal cancer metastasis. Kidney Int 2003; 63: 917-926.